Expertise in
4
conditions

Masahiro Yamamura

Okayama, JP 
Expertise in
4
conditions
Okayama, JP 

Overview

Masahiro Yamamura practices practicing medicine in Okayama, Japan.

Mr. Yamamura is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Non-Radiographic Axial Spondyloarthritis (nr-axSpA), and Vasculitis.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Okayama, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

18 Total Publications

Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two years.
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two years.
Journal: Modern rheumatology
Published: November 26, 2024

Frequently Asked Questions about Masahiro Yamamura

Is Masahiro Yamamura a top-rated expert for Rhizomelic Pseudopolyarthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Masahiro Yamamura is classified as an Distinguished expert for Rhizomelic Pseudopolyarthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masahiro Yamamura participate in research or clinical trials?

Yes. Masahiro Yamamura has published 18 articles and abstracts on conditions like Rhizomelic Pseudopolyarthritis. You can view a list of Masahiro Yamamura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yamamura's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile